Tumour screening and clinical management

Secondary prevention Method in which previous therapeutic intervention is possible through screening an asymptomatic population to recognize cancer at an earlier stage than it would have  been diagnoised in absence of screening.

There are 3 national screening programmes

Bowel cancer screening is seen in people aged 60-74

Breast cancer screening is offered to women, some transgender men and certain non-binary people aged 50-70

Cervical screening is seen in women, some transgender men and some non-binary people aged 25-64 

    Related Conference of Tumour screening and clinical management

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Tumour screening and clinical management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in